Home /
Knowledge hub
Explore our latest insights and expert resources to advance your drug delivery development and manufacturing.
News filter
What’s next for CDMO supply chains?
How CDMOs Can Develop a More Seamless Supply Chain Recent pharmaceutical industry market dynamics have tested the resolve of contract development and manufacturing organizations (CDMOs) of all sizes. To maintain business vitality, several CDMOs have been forced to consider the difficult decision to stop manufacturing products that are too complex or too expensive to make […]
Read more
Missed ss at DDL? Unlock pulmonary & nasal insights with our presentations
Kindeva Drug Delivery presented cutting-edge advancements in pulmonary & nasal development and manufacturing at the Drug Delivery to the Lungs (DDL) conference on December 6-8, 2023. Across eight posters and podium presentations, we highlighted strategies for switching to green propellant formulations while preserving product performance, among a variety of other topics. If you missed any […]
Read more
The pMDI dilemma: managing patient needs, human health, and the planet
While long a topic of discussion, an even brighter spotlight has illuminated the subject of more environmentally friendly inhalers of late, thanks in part to the proposed phasedown on per- and polyfluoroalkyl substances (PFAS). PFAS substances as a class are comprised of thousands of synthetic chemicals that resist degradation because of their exceptionally strong chemical […]
Read more
Promising early results for new high-performance DPI
The αeolus, developed in a collaboration between Kindeva Drug Delivery and Cambridge Healthcare Innovations, is a passive, high-performance, high-consistency dry powder inhaler (DPI) platform concept. This technology has produced promising preliminary results, addressing common concerns with passive DPIs through innovative engineering and novel technologies. Download this article to delve into the performance of the αeolus […]
Read more
Understanding the in-vitro/in-vivo relationship (IVIVR): inhaled medicinal products
In-vitro/in-vivo relationship (IVIVR) modeling leverages in-vitro testing knowledge in order to predict in-vivo results. This can often reduce long-term development costs and facilitate more informed decision making. Download this article to uncover how IVIVR works in practice and how Kindeva has demonstrated expertise in this area.
Read more
Kindeva drug delivery – microneedles
Read more
Kindeva Drug Delivery world vaccine congress presentation
Read more
The History of therapeutic aerosols: A chronological review
Read moreManufacturing More Tomorrows™
Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.
Let’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.